Boston Scientific’s Post

View organization page for Boston Scientific, graphic

1,031,785 followers

We’re excited to share that we have entered into a definitive agreement to acquire Silk Road Medical, Inc., a med tech company focused on stroke prevention in patients with carotid artery disease through the TCAR procedure. Upon close, we look forward to bringing this innovative and clinically differentiated technology to vascular surgeons and welcoming the Silk Road team to Boston Scientific and Peripheral Interventions! https://bit.ly/3XtVUVh

  • No alternative text description for this image

Congratulations to Boston Scientific on this exciting acquisition! The integration of Silk Road Medical's TCAR procedure into your offerings promises to bring significant advancements in stroke prevention for patients with carotid artery disease. This move underscores your commitment to innovative, patient-centric care. Looking forward to seeing the positive impact this will have on the field of vascular surgery! 

Simon Hodgkins

President • CMO • Editor in Chief • Founder

2mo

"The TCAR platform developed by Silk Road Medical, Inc. is a notable advancement in the field of vascular medicine, which has revolutionized stroke prevention and the treatment of carotid artery disease." - Cat Jennings, President, Vascular, Peripheral Interventions, Boston Scientific.

Congratulations on this exciting news! Preventing stroke in patients with Carotid artery disease is truly impactful. We look forward to seeing the innovative work from the talented team at Silk Road Medical, Inc. #strokeprevention #innovation

Great purchase! Give the M&A team tomorrow off!

Chandrabal Kottekkatt

Channel Sales Manager at International Agencies Company Limited

2mo

Critical area where time is of utmost importance in saving and rehabilitation of stroke patients... Need to bring hugs disruptions and innovations to mitigate the suffering of unfortunate victims....😔

Like
Reply
Ashwaq Alijan

Cardiac Monitoring Tech at Boston Scientific

2mo

Congratulations For this news!

Like
Reply
Sabine Molloy

Medical Device & Healthcare Marketing | MBA Candidate ‘25 | UC Irvine MBA Cohort Representative

2mo

Exciting news! This acquisition marks a significant advancement in stroke prevention technology. The addition of the innovative TCAR platform to our vascular portfolio underscores commitment to improving patient outcomes through cutting-edge medical solutions. Looking forward to the transformative impact this will have on vascular medicine! 🌟

Congratulations! #MergerLinks #Medical

Like
Reply
Adil Polat

Sağlık Bilimleri Üniversitesi şirketinde Professor

2mo

Great news 👏

See more comments

To view or add a comment, sign in

Explore topics